These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2425034)

  • 1. Nonoverlapping T and B cell determinants on an hepatitis B surface antigen pre-S(2) region synthetic peptide.
    Milich DR; McLachlan A; Chisari FV; Thornton GB
    J Exp Med; 1986 Aug; 164(2):532-47. PubMed ID: 2425034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune response to the pre-S(1) region of the hepatitis B surface antigen (HBsAg): a pre-S(1)-specific T cell response can bypass nonresponsiveness to the pre-S(2) and S regions of HBsAg.
    Milich DR; McLachlan A; Chisari FV; Kent SB; Thorton GB
    J Immunol; 1986 Jul; 137(1):315-22. PubMed ID: 2423607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single 10-residue pre-S(1) peptide can prime T cell help for antibody production to multiple epitopes within the pre-S(1), pre-S(2), and S regions of HBsAg.
    Milich DR; McLachlan A; Moriarty A; Thornton GB
    J Immunol; 1987 Jun; 138(12):4457-65. PubMed ID: 2438344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of subtype in the immune response to the pre-S(2) region of the hepatitis B surface antigen. I. T cell fine specificity.
    Milich DR; Hughes JL; McLachlan A; Langley KE; Thornton GB; Jones JE
    J Immunol; 1990 May; 144(9):3535-43. PubMed ID: 1691762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). VI. T cell fine specificity.
    Milich DR; Peterson DL; Leroux-Roels GG; Lerner RA; Chisari FV
    J Immunol; 1985 Jun; 134(6):4203-11. PubMed ID: 2580909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of subtype in the immune response to the pre-S(2) region of the hepatitis B surface antigen. II. Synthetic Pre-S(2) immunogen.
    Milich DR; Jones JE; McLachlan A; Bitter G; Moriarty A; Hughes JL
    J Immunol; 1990 May; 144(9):3544-51. PubMed ID: 1691763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B synthetic immunogen comprised of nucleocapsid T-cell sites and an envelope B-cell epitope.
    Milich DR; Hughes JL; McLachlan A; Thornton GB; Moriarty A
    Proc Natl Acad Sci U S A; 1988 Mar; 85(5):1610-4. PubMed ID: 2449694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune response to hepatitis B virus core antigen (HBcAg): localization of T cell recognition sites within HBcAg/HBeAg.
    Milich DR; McLachlan A; Moriarty A; Thornton GB
    J Immunol; 1987 Aug; 139(4):1223-31. PubMed ID: 2440947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct H-2-linked regulation of T-cell responses to the pre-S and S regions of the same hepatitis B surface antigen polypeptide allows circumvention of nonresponsiveness to the S region.
    Milich DR; McNamara MK; McLachlan A; Thornton GB; Chisari FV
    Proc Natl Acad Sci U S A; 1985 Dec; 82(23):8168-72. PubMed ID: 2415982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human T-helper cell responses to a synthetic peptide derived from the hepatitis B surface antigen.
    Mishra A; Rao KV; Durgapal H; Manivel V; Panda SK
    Immunology; 1993 Jul; 79(3):362-7. PubMed ID: 7691722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). IV. Distinct H-2-linked Ir genes control antibody responses to different HBsAg determinants on the same molecule and map to the I-A and I-C subregions.
    Milich DR; Leroux-Roels GG; Louie RE; Chisari FV
    J Exp Med; 1984 Jan; 159(1):41-56. PubMed ID: 6198427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine engineering: enhancement of immunogenicity of synthetic peptide vaccines related to hepatitis in chemically defined models consisting of T- and B-cell epitopes.
    Tam JP; Lu YA
    Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9084-8. PubMed ID: 2480595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). I. H-2 restriction of the murine humoral immune response to the a and d determinants of HBsAg.
    Milich DR; Chisari FV
    J Immunol; 1982 Jul; 129(1):320-5. PubMed ID: 6177755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specificity of antibodies reactive with hepatitis B surface antigen following immunization with synthetic peptides.
    Steward MW; Partidos CD; D'Mello F; Howard CR
    Vaccine; 1993 Nov; 11(14):1405-14. PubMed ID: 7508664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell recognition of pre-S regions of HBsAg can bypass nonresponse to the S region.
    Milich DR; McLachlan A; Thornton GB
    Adv Exp Med Biol; 1987; 225():233-9. PubMed ID: 2455965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mimicry of the a determinant of hepatitis B surface antigen by an antiidiotypic antibody. I. Evaluation in hepatitis B surface antigen responder and nonresponder strains.
    Pride MW; Thakur A; Thanavala Y
    J Exp Med; 1993 Jan; 177(1):127-34. PubMed ID: 7678109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of T cell epitopes on hepatitis B surface antigen.
    Vento S
    Ann Ist Super Sanita; 1991; 27(1):37-40. PubMed ID: 1720295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
    Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
    J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody production to the nucleocapsid and envelope of the hepatitis B virus primed by a single synthetic T cell site.
    Milich DR; McLachlan A; Thornton GB; Hughes JL
    Nature; 1987 Oct 8-14; 329(6139):547-9. PubMed ID: 2443856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of synthetic immunogen: use of new T-helper epitope on malaria circumsporozoite protein.
    Good MF; Maloy WL; Lunde MN; Margalit H; Cornette JL; Smith GL; Moss B; Miller LH; Berzofsky JA
    Science; 1987 Feb; 235(4792):1059-62. PubMed ID: 2434994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.